Browsing eNauka
Browsing by Author Meisel, Andreas
Showing results 1 to 8 of 8
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2016 | Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMS | Oh, Shin J; Shcherbakova, Natalya; Kostera-Pruszczyk, Anna; Alsharabati, Mohammad; Dimachkie, Mazen; Blanco, Jose Munoz; Brannagan, Thomas; Lavrnić, Dragana  ; Shieh, Perry B; Vial, Christophe;
Meisel, Andreas; Komoly, Samuel; Schoser, Benedikt; Sivakumar, Kumaraswamy; So, Yuen;
| Article | 22M22 |
| 2016 | Amifampridine Phosphate in patients with Lambert-Eaton myasthenic syndrome (LEMS): a phase 3, multicentre, double-blind, placebo-controlled trial | Schoser, B; Oh, S; Shcherbakova, N; Kostera-Pruszczyk, A; Alsharabati, M; Dimachkie, M; Blanco, JM; Lavrnic, Dragana V; Shieh, P; Vial, C;
Meisel, Andreas; Brannagan, T; Komoly, S; Sivakumar, K; So, Y;
| Conference Paper | Mp. category will be shown later |
| 2022 | Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies | Howard, James F Jr; Bril, Vera; Tuan, Vu; Karam, Chafic; Perić, Stojan Z.  ; De Bleecker, Jan L.; Murai, Hiroyuki; Pasnoor, Mamatha; Sacca, Francesco; Meisel, Andreas;
Guglietta, Antonio; T'joen, Caroline; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato;
| Conference Paper | Mp. category will be shown later |
| 2023 | Efgartigimod Demonstrates Consistent Magnitude of Response Across Subgroups of Patients With gMG | Hoffmann, S.; Meisel, Andreas; Attarian, S.; De Bleecker, J.; Vissing, J.; Kerstens, R.; Brauer, E.; Utsugisawa, Kimiaki; Goyal, N.; Li, Y.;
Perić, Stojan Z.
; Howard, J; Sacca, Francesco; | Conference Paper | Mp. category will be shown later |
| 2022 | Long-term Safety and Efficacy of Efgartigimod in Patients With Generalised Myasthenia Gravis | Meisel, Andreas; ...; Perić, Stojan Z. ; ...; (broj koautora 16) | Conference Paper | Mp. category will be shown later |
| 2022 | Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study | Howard, James F Jr.; Bril, Vera; Tuan, Vu; Karam, Chafic; Perić, Stojan Z. ; De Bleecker, Jan L.; Murai, Hiroyuki; Meisel, Andreas; Beydoun, Said; Pasnoor, Mamatha;
Guglietta, Antonio; T'joen, Caroline; Utsugisawa, Kimiaki; Verschuuren, Jan; Mantegazza, Renato;
| Conference Paper | Mp. category will be shown later |
| 2023 | Long-Term Safety, Tolerability, And Efficacy of Efgartigimod In Patients With gMG: Final Analyses From The ADAPT+ Study | Meisel, Andreas; ...; Perić, Stojan Z. ; ...; (broj koautora 16) | Conference Paper | Mp. category will be shown later |
| 2021 | PHACTR1 genetic variability is not critical in small vessel ischemic disease patients and PcomA recruitment in C57BL/6J mice | Messerschmidt, Clemens; Foddis, Marco; Blumenau, Sonja; Müller, Susanne; Bentele, Kajetan; Holtgrewe, Manuel; Kun-Rodrigues, Celia; Alonso, Isabel; do Carmo Macario, Maria; Morgadinho, Ana Sofia;
Velon, Ana Graça; Santo, Gustavo; Santana, Isabel; Mönkäre, Saana; Kuuluvainen, Liina; Schleutker, Johanna; Pöyhönen, Minna; Myllykangas, Liisa; Senatore, Assunta; Berchtold, Daniel; Winek, Katarzyna; Meisel, Andreas; Pavlović, Aleksandra
; Kostić, Vladimir; Dobricic, Valerija; Lohmann, Ebba; Hanagasi, Hasmet; Guven, Gamze; Bilgic, Basar; Bras, Jose; Guerreiro, Rita; Beule, Dieter; Dirnagl, Ulrich; Sassi, Celeste; | Article | 21aM21a |